Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 10,601	$ 12,217
Restricted cash - current	88	219
Accounts receivable, net of allowance of $556 and $582 at 2025 and 2024, respectively	4,324	3,824
Inventories, net	9,812	8,331
Prepaid expenses and other current assets	1,088	1,848
Total current assets	25,913	26,439
Property and equipment, net	3,441	3,573
Goodwill	3,764	3,764
Intangible assets, net	7,144	7,358
Operating lease right-of-use assets	5,345	5,483
Prepaid and other non-current assets	98	107
Total assets	45,705	46,724
Current liabilities:
Accounts payable	6,544	5,668
Accrued liabilities	2,926	2,922
Deferred revenue	8,163	6,804
Current contingent consideration	6,008	5,638
Current portion of operating lease liabilities	588	570
Total current liabilities	24,229	21,602
Long-term deferred revenue	1,698	2,064
Long term contingent consideration	6,258	6,126
Operating lease liabilities	5,280	5,436
Other liabilities	64	64
Total liabilities	37,529	35,292
Series A - Convertible preferred stock:
Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized; 21,233 and 21,458 shares outstanding at 2025 and 2024, respectively	5,296	5,352
Stockholders’ equity:
Common stock, par value $0.001; 300,000,000 shares authorized, 85,983,677 and 85,326,557 shares issued at 2025 and 2024, respectively	86	85
Additional paid in capital	570,548	567,926
Treasury stock, 4,015 shares at 2025 and 2024	(206)	(206)
Accumulated deficit	(567,548)	(561,725)
Total stockholders’ equity	2,880	6,080
Total liabilities and stockholders’ equity	$ 45,705	$ 46,724